Objective:
To discuss the prevalence and management of dry eye disease (DED) and meibomian gland dysfunction (MGD) in younger populations, specifically children and young adults.
Approach:
- 5.5% to 23% of the pediatric population (ages 5-18) in the U.S. is affected by DED.
- 31% of affected children show severe meibomian gland atrophy.
- Digital device use exceeding 2-3 hours daily significantly contributes to ocular surface changes.
- Lack of mandatory recall system for harmful cosmetic ingredients in the U.S. is significant as it limits consumer safety.
- Only 11 harmful ingredients are banned, and not all need to be listed on product labels.
Key Findings:
Interpretation:
The increasing prevalence of MGD in younger populations necessitates early identification and tailored management strategies, particularly considering lifestyle and cosmetic product use.
Limitations:
Conclusion:
Effective management of dry eye in younger patients requires consistent protocols, education, and accessibility to treatments, urging practitioners to adopt these strategies.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
